Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Acta Pharmaceutica
Volume 66 (2016): Numero 4 (December 2016)
Accesso libero
Pleiotropic effects of niacin: Current possibilities for its clinical use
Miroslav Zeman
Miroslav Zeman
,
Marek Vecka
Marek Vecka
,
František Perlík
František Perlík
,
Barbora Staňková
Barbora Staňková
,
Robert Hromádka
Robert Hromádka
,
Eva Tvrzická
Eva Tvrzická
,
Jakub Širc
Jakub Širc
,
Jakub Hrib
Jakub Hrib
e
Aleš Žák
Aleš Žák
| 15 ott 2016
Acta Pharmaceutica
Volume 66 (2016): Numero 4 (December 2016)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
15 ott 2016
Pagine:
449 - 469
Accettato:
02 giu 2016
DOI:
https://doi.org/10.1515/acph-2016-0043
Parole chiave
niacin
,
pleiotropic effects
,
HCA2 receptor
,
dyslipidemia
,
cardiovascular mortality/morbidity
© by Miroslav Zeman
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Miroslav Zeman
4th Department of Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czechia
Marek Vecka
4th Department of Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czechia
František Perlík
Institute of Pharmacology, 1st Faculty of MedicineCharles University in Prague, Prague, Czechia
Barbora Staňková
4th Department of Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czechia
Robert Hromádka
Research and Development Center, C2P s.r.o., Chlumec/n Cidlinou, Czechia
Eva Tvrzická
4th Department of Medicine, 1st Faculty of Medicine, Charles University in PraguePrague, Czechia
Jakub Širc
Institute of Macromolecular, Chemistry, Academy of Sciences of the Czech Republic Prague, Czechia
Jakub Hrib
Institute of Macromolecular, Chemistry, Academy of Sciences of the Czech Republic Prague, Czechia
Aleš Žák
4th Department of Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czechia